355 related articles for article (PubMed ID: 28017148)
1. Chemical Structure and Surface Modification of Dendritic Nanomaterials Tailored for Therapeutic and Diagnostic Applications.
Myung JH; Hsu HJ; Bugno J; Tam KA; Hong S
Curr Top Med Chem; 2017; 17(13):1542-1554. PubMed ID: 28017148
[TBL] [Abstract][Full Text] [Related]
2. Amine-terminated dendritic polymers as promising nanoplatform for diagnostic and therapeutic agents' modification: A review.
Delyanee M; Akbari S; Solouk A
Eur J Med Chem; 2021 Oct; 221():113572. PubMed ID: 34087497
[TBL] [Abstract][Full Text] [Related]
3. The Present and the Future of Degradable Dendrimers and Derivatives in Theranostics.
Leiro V; Garcia JP; Tomás H; Pêgo AP
Bioconjug Chem; 2015 Jul; 26(7):1182-97. PubMed ID: 25826129
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo applications of 3D dendritic gold nanostructures.
Bolocan A; Mihaiescu DE; Meşterca AR; Spirescu VA; Tote EM; Mogoantă L; Mogoşanu GD; Grumezescu AM
Rom J Morphol Embryol; 2015; 56(3):915-24. PubMed ID: 26662123
[TBL] [Abstract][Full Text] [Related]
5. Dendritic nanoparticles: the next generation of nanocarriers?
Pearson RM; Sunoqrot S; Hsu HJ; Bae JW; Hong S
Ther Deliv; 2012 Aug; 3(8):941-59. PubMed ID: 22946429
[TBL] [Abstract][Full Text] [Related]
6. Gene delivery efficiency and cytotoxicity of heterocyclic amine-modified PAMAM and PPI dendrimers.
Hashemi M; Tabatabai SM; Parhiz H; Milanizadeh S; Amel Farzad S; Abnous K; Ramezani M
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():791-800. PubMed ID: 26838910
[TBL] [Abstract][Full Text] [Related]
7. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.
Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L
Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983
[TBL] [Abstract][Full Text] [Related]
8. Advances in drug delivery, gene delivery and therapeutic agents based on dendritic materials.
Contin M; Garcia C; Dobrecky C; Lucangioli S; D'Accorso N
Future Med Chem; 2019 Jul; 11(14):1791-1810. PubMed ID: 31368345
[TBL] [Abstract][Full Text] [Related]
9. Dendrimers: A versatile nanocarrier for drug delivery and targeting.
Sherje AP; Jadhav M; Dravyakar BR; Kadam D
Int J Pharm; 2018 Sep; 548(1):707-720. PubMed ID: 30012508
[TBL] [Abstract][Full Text] [Related]
10. Smart triblock dendritic unimolecular micelles as pioneering nanomaterials: Advancement pertaining to architecture and biomedical applications.
Tambe P; Kumar P; Paknikar KM; Gajbhiye V
J Control Release; 2019 Apr; 299():64-89. PubMed ID: 30797002
[TBL] [Abstract][Full Text] [Related]
11. Bifunctional Phosphorus Dendrimers and Their Properties.
Caminade AM; Majoral JP
Molecules; 2016 Apr; 21(4):538. PubMed ID: 27120586
[TBL] [Abstract][Full Text] [Related]
12. Dendrimers as versatile platform in drug delivery applications.
Svenson S
Eur J Pharm Biopharm; 2009 Mar; 71(3):445-62. PubMed ID: 18976707
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of nanoscale dendritic RGD clusters for potential applications in tissue engineering and drug delivery.
Yang H; Kao WJ
Int J Nanomedicine; 2007; 2(1):89-99. PubMed ID: 17722516
[TBL] [Abstract][Full Text] [Related]
14. Dendrimer-based nanocarriers: a versatile platform for drug delivery.
Hsu HJ; Bugno J; Lee SR; Hong S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27126551
[TBL] [Abstract][Full Text] [Related]
15. Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications.
Yellepeddi VK; Kumar A; Palakurthi S
Expert Opin Drug Deliv; 2009 Aug; 6(8):835-50. PubMed ID: 19637972
[TBL] [Abstract][Full Text] [Related]
16. Dendritic supermolecules--towards controllable nanomaterials.
Smith DK
Chem Commun (Camb); 2006 Jan; (1):34-44. PubMed ID: 16353086
[TBL] [Abstract][Full Text] [Related]
17. Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting.
Bugno J; Hsu HJ; Hong S
J Drug Target; 2015; 23(7-8):642-50. PubMed ID: 26453160
[TBL] [Abstract][Full Text] [Related]
18. Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery.
Sharma AK; Gothwal A; Kesharwani P; Alsaab H; Iyer AK; Gupta U
Drug Discov Today; 2017 Feb; 22(2):314-326. PubMed ID: 27671487
[TBL] [Abstract][Full Text] [Related]
19. Toxicology of Engineered Nanoparticles: Focus on Poly(amidoamine) Dendrimers.
Naha PC; Mukherjee SP; Byrne HJ
Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29443901
[TBL] [Abstract][Full Text] [Related]
20. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery.
Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK
Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
